The maker of opioid painkiller Opana ER is pulling the drug off the market at the request of federal regulators because it’s being abused. Opioid Opana ER, approved in 2006, is too risky, the FDA says. Currently, there are no generic versions on the market.…
A state court jury in Philadelphia has returned a $20 million verdict against Johnson & Johnson’s Ethicon division, including punitive damages designed to punish the manufacturer over problems with the Ethicon TVT-Secur transvaginal mesh. The 12-member jury hearing the case returned the verdict after testimony…
Taxotere (docetaxel) is a popular chemotherapy drug manufactured and marketed by Sanofi-Aventis. Doctors prescribe the drug to treat the majority of breast cancer cases in the U.S., and each year about 300,000 women are diagnosed with the disease. The drug is also the most prescribed…
Canagliflozin is prescribed alongside diet and exercise to help patients with type 2 diabetes lower their blood sugar. It inhibits the sodium-glucose cotrasporter-2, and its effects are measured through the amount of sugar in the patient’s urine, as the drug focuses its effects on the…
The U.S. Food and Drug Administration has cited local generic drug giant Mylan for “significant violations” of manufacturing regulations at a plant in Nashik, India, according to a warning letter released by the agency Tuesday. The FDA conducted inspections at the plant from Sept. 5-14…
The side effects of a Mirena IUD caused a Pennsylvania woman to develop severe migraine headaches, blurred vision and a host of other health problems associated with the buildup of fluid pressure around her brain, according to allegations raised in a lawsuit recently filed against…